Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane with dexmedetomidine for prevention of postoperative neurocognitive impairment in elderly surgical patients
ChiCTR1900023385Phase 4Recruiting
- Sponsor
- The First People's Hospital of Shuangliu District, Chengdu
- Start
- May 2019
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of desflurane and dexmedetomidine in post-operative cognitive decline (POCD) (2 arms), sponsored by The First People's Hospital of Shuangliu District, Chengdu. Primary endpoint: MMSE score before anesthesia and 24 hours after surgery. Started May 2019; status: recruiting.
02
Drugs
desfluranedexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR1900023385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023385.